Literature DB >> 10101658

Is there still a place for angiography in the management of renal mass lesions?

C Roy1, C Tuchmann, M Morel, C Saussine, D Jacqmin, J Tongio.   

Abstract

In recent years, the development of noninvasive imaging modalities for exploration of the kidney has markedly reduced the use of angiography in the evaluation of renal masses. Presently, it is not required in routine practice to evaluate renal masses. Ultrasound is the most efficient procedure in detecting renal tumor. It is acknowledged that arteriography has a limited diagnostic and staging value compared with CT and MRI for the assessment of renal cell carcinomas (RCC). Most urologists recommend partial nephrectomy or tumor enucleation in an effort to preserve as much as possible functioning renal tissue. In such cases a preoperative map of the renal vasculature is not needed. Information on the main renal artery(ies) and segmental renal arteries can be provided with spiral CT or dynamic MR angiography. Arteriography remains useful in exceptional situations. Interventional arteriography is becoming an important part. It is indicated by means of selective embolization for the treatment of potentially bleeding tumor (i.e. angiomyolipoma) or in emergency in cases of acute hemorrhage. Less frequently, it may be proposed as a palliative procedure for inoperable patients with huge renal tumor. Two other indications of interventional arteriography are acknowledged. Some urologists request preoperative embolization of the tumor-harboring kidney to decrease/avoid extensive blood loss during surgery and/or to facilitate surgery with huge renal tumors when the renal vessels are difficult to reach. The complications of nephron-sparing surgery (partial nephrectomy or tumor enucleation) related to bleeding or arteriovenous fistulas may be cured by arterial embolization.

Entities:  

Mesh:

Year:  1999        PMID: 10101658     DOI: 10.1007/s003300050675

Source DB:  PubMed          Journal:  Eur Radiol        ISSN: 0938-7994            Impact factor:   5.315


  8 in total

1.  Embolization of nonliver visceral tumors.

Authors:  Paul G Thacker; Jeremy L Friese; Matthew Loe; Peter Biegler; Michael Larson; James Andrews
Journal:  Semin Intervent Radiol       Date:  2009-09       Impact factor: 1.513

2.  Contrast enhanced ultrasound of renal masses.

Authors:  Andre Ignee; Bernd Straub; Gudrun Schuessler; Christoph Frank Dietrich
Journal:  World J Radiol       Date:  2010-01-28

Review 3.  Cancer concepts and principles: primer for the interventional oncologist-part II.

Authors:  Ryan Hickey; Michael Vouche; Daniel Y Sze; Elias Hohlastos; Jeremy Collins; Todd Schirmang; Khairuddin Memon; Robert K Ryu; Kent Sato; Richard Chen; Ramona Gupta; Scott Resnick; James Carr; Howard B Chrisman; Albert A Nemcek; Robert L Vogelzang; Robert J Lewandowski; Riad Salem
Journal:  J Vasc Interv Radiol       Date:  2013-06-28       Impact factor: 3.464

4.  Persistent hematuria caused by renal cell carcinoma after aortic valve replacement and warfarin therapy.

Authors:  Sumera Bukhari; Afolarin Amodu; Michael Akinyemi; Sara Wallach
Journal:  Proc (Bayl Univ Med Cent)       Date:  2017-07

Review 5.  Preoperative imaging in renal cell cancer.

Authors:  Axel Heidenreich; Vincent Ravery
Journal:  World J Urol       Date:  2004-07-30       Impact factor: 4.226

Review 6.  A Concise Review of the Multimodality Imaging Features of Renal Cell Carcinoma.

Authors:  Ali Morshid; Elif S Duran; Woongsoon J Choi; Cihan Duran
Journal:  Cureus       Date:  2021-02-08

7.  Pilot study of transcatheter arterial ethanol embolization under closed renal circuit for large renal cell carcinomas.

Authors:  Satoru Murata; Hiroyuki Tajima; Shiro Onozawa; Shinichiro Kumita; Yukihiro Kondo; Kazuhiro Nomura
Journal:  Eur Radiol       Date:  2008-03-20       Impact factor: 7.034

8.  Embolisation of cancer: what is the evidence?

Authors:  J A Goode; M B Matson
Journal:  Cancer Imaging       Date:  2004-09-17       Impact factor: 3.909

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.